thyrotropin receives extended european label
Post on 12-Dec-2016
213 views
TRANSCRIPT
Inpharma 1407 - 4 Oct 2003
■ Thyrotropin alfa [‘Thyrogen’; GenzymeCorporation] has received an extended Europeanlabel. ‘Thyrogen’, a recombinant human thyroidstimulating hormone, is used in the management ofpatients being followed for the recurrence of well-differentiated thyroid cancer. Now, the European labelfor ‘Thyrogen’ no longer requires whole body scanningto be part of the follow-up test used to determine anyrecurrence of thyroid cancer.Genzyme Corporation. Genzyme Receives Extended European Label forThyrogen. Media Release : 25 Sep 2003. Available from: URL: http://www.genzyme.com 809025888
1
Inpharma 4 Oct 2003 No. 14071173-8324/10/1407-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved